Supernus Pharmaceuticals, Inc. - Common Stock (NQ:SUPN)
Price and Volume
Detailed Quote| Volume | 0 |
| Open | 39.57 |
| Bid (Size) | 38.65 (100) |
| Ask (Size) | 40.50 (100) |
| Prev. Close | 39.57 |
| Today's Range | 39.57 - 39.57 |
| 52wk Range | 39.36 - 59.68 |
| Shares Outstanding | 53,145,884 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
33.7% below 52-week high
39.57
39.3652W Low
59.6852W High
1 Week
8.6% below 1-week high
39.361W Low
43.291W High
Supernus Pharmaceuticals, Inc. - Common Stock (SUPN) traded between $39.36 and $59.68 over the past 52 weeks and last traded at $39.57, 33.7% below its 52-week high. Over the past week it ranged between $39.36 and $43.29.
Past 12 Months
1W
-$3.10
1M
-$1.71
3M
-$8.64
6M
-$9.65
YTD
-$9.90
1Y
-$9.70
SUPN was -19.7% over the past year, -19.6% over six months, -20.0% year to date, -7.3% in the last week.
12 Months vs Market
SUPN
-19.7%
DIA
+12.6%
SPY
+16.0%
QQQ
+20.9%
IWM
+9.9%
Over the past 12 months SUPN returned -19.7% versus DIA (Dow) +12.6%, SPY (S&P 500) +16.0%, QQQ (Nasdaq 100) +20.9% and IWM (Russell 2000) +9.9%.
Volume & Liquidity
1W
935.0K
1M
754.1K
3M
769.6K
6M
772.5K
YTD
748.7K
1Y
765.1K
SUPN's 3-month average daily volume is 769.6K.
More News
Read More
1 Unprofitable Stock with Impressive Fundamentals and 2 We Avoid
September 30, 2026
2 Growth Stocks to Add to Your Roster and 1 We Question
September 28, 2026
3 Reasons SUPN is Risky and 1 Stock to Buy Instead
September 21, 2026
3 Cash-Heavy Stocks Walking a Fine Line
September 16, 2026
Supernus Pharmaceuticals to Participate in September Investor Conferences
September 02, 2026
3 Out-of-Favor Stocks We’re Skeptical Of
September 02, 2026
3 Small-Cap Stocks with Open Questions
August 25, 2026
1 Healthcare Stock with Exciting Potential and 2 We Ignore
August 18, 2026
3 Russell 2000 Stocks We Approach with Caution
August 14, 2026
Why Supernus Pharmaceuticals Stock Topped the Market Today ↗
August 03, 2026
Supernus Pharmaceuticals Q2 Earnings Call Highlights ↗
August 03, 2026
What's going on in today's pre-market session ↗
August 03, 2026
Supernus Announces Second Quarter 2026 Financial Results
August 03, 2026
Frequently Asked Questions
Is Supernus Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Supernus Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Supernus Pharmaceuticals, Inc. - Common Stock trade on?
Supernus Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock is SUPN on the Nasdaq Stock Market
What is the current price of Supernus Pharmaceuticals, Inc. - Common Stock?
The current price of Supernus Pharmaceuticals, Inc. - Common Stock is 39.57
When was Supernus Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Supernus Pharmaceuticals, Inc. - Common Stock was at 10/15/26 04:00 PM ET
What is the market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock is 2.10B
How many shares of Supernus Pharmaceuticals, Inc. - Common Stock are outstanding?
Supernus Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.